circular-economy · manufacturing · environment · family: the solution exists but nobody can afford it
twenty years of research,still twice the price
PHA bioplastics cost 2–10× more than petroleum plastics after 20 years of development
Problem statement
Polyhydroxyalkanoates (PHAs) are biodegradable polyesters produced by microbial fermentation — among the most biodegradable polymers on the market, degrading in a wide range of natural environments including the ocean, where polyethylene and polypropylene keep accumulating. Despite several decades of commercialization attempts, biobased biodegradable plastics still cost 2–10 times as much to produce as conventional plastics, whose price (polyethylene) had fallen to around 1 €/kg by 2020. Danimer Scientific, described in 2021 as the company leading the charge for PHA ($380M raised in its 2020 SPAC listing), filed for bankruptcy in March 2025 and was sold for $19M. Revenue declined for three consecutive years ($79.5M → $53.6M → $51.8M) despite having commercial products, and a $515–665M factory expansion never generated production. The cost gap persists because of three compounding barriers: high carbon substrate (feedstock) costs, low volumetric fermentation yields, and complex downstream extraction and purification.
Why this matters
Conventional plastics do not degrade at end of life and leave persistent micro- and nanoplastics behind. PHAs are among the most biodegradable of the commercial bioplastics (PLA, by contrast, is certified only for industrial composting), making them relevant for applications whose likely fate is the natural environment (fishing gear, agricultural mulch films, food packaging). If PHA costs cannot reach parity with polyolefins, PHA remains unavailable at scale for those uses. Cities are banning plastic straws and take-out containers, and straws were Danimer's biggest-volume product in 2021, but the customer commitments Danimer expected failed to materialize at scale and its plants were running at about 15% of capacity before the filing.
What’s been tried and why it hasn’t worked
Danimer invested about $189.5M in a greenfield production expansion in Bainbridge, Georgia; construction was paused after delays in customer adoption, and the expansion was halted during restructuring. The fundamental fermentation challenges: PHA-producing bacteria (e.g., Cupriavidus necator) accumulate PHA as intracellular storage granules, and current processes fall far short of the chemical industry's productivity benchmark of 100 g/l/h. Recovering the granules from the cells (downstream processing, typically solvent-based for medium-chain-length PHAs) accounts for 50% or more of total production cost; recovery and purification of short-chain-length PHA alone runs 1.1–5 €/kg. Meeting the property targets of petroleum plastics requires further formulation and compounding work (Danimer blends its PHA with PLA), and hydrolytic stability during processing is often compromised. Waste-stream feedstocks (used with mixed microbial cultures at lab scale) promise cheaper substrate but vary in composition by season and region, making constant polymer quality a challenge. End-of-life infrastructure compounds the market challenge — the collection, sorting and recycling routes for small bioplastic waste streams are underdeveloped, and small volumes make identification and sorting uneconomic.
What would unlock progress
Raising fermentation productivity while keeping cell density and PHA content high: the Frontiers perspective's illustrative case of 100 g/l cell density, a growth rate of 0.5 h⁻¹ and 80% PHA content in continuous fermentation would yield productivity more than 20-fold higher than the state of the art in continuous PHA production, and would also simplify downstream processing. Cheaper, more sustainable feedstocks — organic waste streams, methane-rich gases and CO₂ — are at lower maturity but moving from lab to pilot and first-of-a-kind scale. Solvent-free recovery of short-chain-length PHA granules may be 50% cheaper, and higher-productivity fermentation could allow direct processing of PHA-containing biomass. Non-biological routes to PHA (catalytic polymerization, as in the Rinnovo technology Danimer acquired with Novomer) could bypass fermentation entirely.
Entry points for student teams
A team could perform a comparative techno-economic analysis of PHA production routes: pure-culture fermentation, mixed-culture waste valorization, and direct chemical synthesis from bio-derived hydroxyalkanoic acids. A more experimental team could compare solvent-free and solvent-based recovery of PHA from a laboratory culture and measure the trade-off between recovery cost and polymer purity. Relevant disciplines: metabolic engineering, chemical engineering, polymer science, environmental engineering.
Genes
Structural cousins: stuck the same way, in other fields
Sources
Bondoro, "Case Summary: Danimer Scientific Chapter 11," 2025, Plastics News, "Bioplastics maker Danimer Scientific files for bankruptcy," 2025; Alexander H. Tullo, C&EN, "Will the biodegradable plastic PHA finally deliver?", June 13, 2021, Volume 99, Issue 22, Tim Börner and Manfred Zinn, "Key challenges in the advancement and industrialization of biobased and biodegradable plastics: a value chain overarching perspective," Front. Bioeng. Biotechnol., Volume 12, 11 July 2024, accessed 2026-02-20 go to source 1 ↗ go to source 2 ↗ go to source 3 ↗
Working notes
Notes made while writing and checking this brief, shown as written. They use working shorthand.
Danimer Scientific's bankruptcy ($380M raised, sold for $19M) is the highest-profile PHA failure but the cost gap is industry-wide — no PHA producer globally has achieved cost parity with polyolefins. Newlight Technologies and Kaneka continue production. Related: circular-plastic-recycling-quality-cost-barrier (different approach to plastic circularity), chemistry-synbio-commodity-molecule-cost-floor (same fermentation cost-floor challenge for different target molecules). The almost-cluster signal `infrastructure` + `unviable-economics` + `prototype` is relevant here (end-of-life infrastructure gap + production economics).
Reconciliation 2026-09-30: Read the whole write-up against its sources; a second reader went over the repairs the same day, opened the same sources independently, and reworded several. Three of the four sources were read in full on 2026-09-30: the Bondoro case summary (https://bondoro.com/danimer-scientific/, direct), the C&EN feature by Alexander H. Tullo (https://cen.acs.org/business/biobased-chemicals/biodegradable-plastic-PHA-finally-deliver/99/i22, direct, full article text), and the Frontiers perspective by Börner and Zinn (https://doi.org/10.3389/fbioe.2024.1406278, the publisher's full-text page, with the Europe PMC record PMC11269247 and the Crossref record for the citation). The Plastics News bankruptcy story could not be read by either reader: the publisher returns "Access Denied" to scripts (article page, guessed addresses and RSS feed alike), the Internet Archive was offline during this pass, and archive.today holds no copy. Changes: (1) The title said PHA costs "2–4×" more than petroleum plastics; the Frontiers paper says fermentation-made biobased biodegradable plastics cost "2–10 times higher" to produce than conventional plastics, and no source gives 2–4×. The title now says 2–10×. (2) The text gave PHA production cost as "$4–6/kg versus $1–2/kg" for polyolefins; no source gives those figures. The sentence now carries the Frontiers 2–10× ratio and its polyethylene price of "around 1 €/kg" by 2020. (3) "Despite 20+ years of development" became "several decades of commercialization attempts" (C&EN: "Companies have been trying to commercialize them—via industrial fermentation—for several decades"; the Frontiers paper puts first commercialization around 50 years ago; Danimer itself dates from 2004). (4) PHA was called "the only commercially viable bioplastic that fully degrades in ocean environments" and "the only known bioplastic that biodegrades in marine environments." No source says PHA is the only such bioplastic (Bondoro says Danimer's Nodax "uniquely biodegrades across oceans, freshwater, and landfills," a product description, not a claim about all bioplastics). C&EN quotes Ramani Narayan that PHA is "one of the most biodegradable polymers on the market" and that a bottle in the ocean lasts several years before microbes remove it, "which is better than polyethylene and polypropylene, which will keep on accumulating"; Frontiers says PHAs are "widely biodegradable in natural and engineered environments" while PLA is "only certified for industrial composting conditions." The Problem Statement now says PHA is among the most biodegradable polymers on the market and degrades in the ocean; the Why This Matters sentence says PHAs are among the most biodegradable of the commercial bioplastics (the second reader softened the first repair's "the most widely biodegradable" to "among," matching C&EN's "one of the most"), and "the leading biodegradable alternative" became simply PHA, since Frontiers gives PLA the largest market share. (5) "Peak market cap >$7B" is in no readable source (C&EN gives a market capitalization of nearly $2.3 billion in June 2021); removed. "$380M raised" is confirmed in C&EN and now says it was raised in the 2020 SPAC listing; "the most prominent PHA producer" now reads "described in 2021 as the company leading the charge for PHA" (C&EN: "The company leading the current charge for PHA is Danimer"). (6) The waste figures "380 million tonnes" and "8–12 million tonnes entering oceans" are in no source; replaced with the Frontiers statement that conventional plastics leave persistent micro- and nanoparticles. (7) "Single-use plastic bans ... have not generated sufficient demand at current PHA price premiums" is not what the sources say; the sentence now reports what they do say: cities are banning straws and take-out containers and straws for jurisdictions with bans were Danimer's biggest-volume product in 2021 (C&EN), and "anticipated customer commitments failed to materialize at scale" with plants at "approximately 15% of total capacity" (Bondoro). (8) The Bainbridge expansion "never produced at commercial scale" now follows Bondoro: construction "was paused following delays in key customer adoption" and the expansion was "halted during restructuring," with the $189.5M given as approximate as Bondoro does; the second reader dropped the first repair's "before it produced," which Bondoro does not say. (9) The nutrient-limitation mechanism ("nutrient limitation also reduces growth rate, creating a tension...") is in no source; replaced with the Frontiers point that current processes fall short of the chemical industry's 100 g/l/h productivity benchmark. (10) Extraction was said to add "30–50%" to production cost and to require solvent-based purification. Frontiers says downstream processing contributes "≥50%" of total production costs, that short-chain-length PHA can be "recovered and purified today at costs of 1.1—5 €/kg PHA," that solvent-free recovery exists for short-chain PHAs, and that solvent-based methods are "typically needed for mcl-PHAs." The sentence now says that, with the 1.1–5 €/kg figure tied to short-chain-length PHA as the source has it. (11) "Consistent molecular weight distribution" is not in the sources; the sentence now gives the Frontiers points that formulation and compounding work is needed (Danimer blends PHA with PLA) and hydrolytic stability during processing is often compromised. (12) Mixed cultures "reduce substrate costs but produce PHAs with variable composition" became the Frontiers version: waste-stream feedstocks vary by season and region, making constant polymer quality a challenge; mixed cultures are at lab scale. (13) "PHA products require industrial composting to biodegrade quickly" contradicts both Frontiers and C&EN, which say PHA degrades widely in natural environments; the sentence now describes the end-of-life infrastructure gap Frontiers does name ("collection, sorting and recycling" of small bioplastic waste streams, which must reach sufficient volumes for identification and sorting to be economically feasible). The Source Notes phrase "composting infrastructure gap" became "end-of-life infrastructure gap" to match. (14) "Typical 50–80% of dry cell weight" and a "2–3×" productivity gain are in no source; the paragraph now gives the Frontiers illustrative case (100 g/l cell density, 0.5 h⁻¹ growth, 80% PHA content, "a >20 fold higher productivity" over the state of the art in continuous production). (15) "Reduce substrate costs by 50%+" and "waste cooking oil" are in no source; the feedstock sentence now names the alternative feedstocks Frontiers discusses (organic waste streams, methane-rich gases, CO₂) and their maturity (lab to pilot and first-of-a-kind scale). (16) Secretion-based PHA production is in no source; replaced with the Frontiers points that "Solvent-free recovery of scl-PHA granules (Latex) may be 50% cheaper" and that higher-productivity fermentation would "enable direct processing of PHA-biomass." The experimental entry point that depended on secretion now proposes comparing solvent-free and solvent-based recovery. (17) The chemical route is now tied to what Bondoro says: Novomer's "catalytic polymerization technology" for Rinnovo; "from bio-derived monomers" was dropped from that sentence because no source says what Rinnovo's monomers are. (18) Source Notes said "$380M invested"; C&EN says raised; changed. "Newlight Technologies (AirCarbon) and Kaneka (PHBH) ... at premium pricing" lost the brand names and the pricing claim, which no source gives; both companies are named as PHA producers in Frontiers. (19) Source line: the Frontiers entry now carries the authors, full title, journal, volume, date and DOI copied from the publisher page (Crossref and Europe PMC agree); the C&EN entry now carries the author, date, volume and issue from the page. Confirmed in the sources and left as written: Chapter 11 filing in March 2025 (March 18, Bondoro); Bainbridge, Georgia; about $189.5M invested in the paused expansion; the three barriers of feedstock cost, fermentation productivity and downstream processing (Frontiers); Cupriavidus necator as a PHA producer (named in the Frontiers reference list); that no producer has reached cost parity (Frontiers: BBPs "not yet competitive to conventional plastics"). Could not be checked, because they would sit in the unreadable Plastics News story or in no readable source, and are left as written: the sale for $19M; the revenue series $79.5M → $53.6M → $51.8M (Bondoro gives $37.4M for the twelve months to September 30, 2024, down from $51.1M, a different period); the $515–665M expansion figure (C&EN reports a planned $700 million plant; Bondoro gives $189.5M invested). Title changed: long title "2–4×" → "2–10×"; the Display title "Still Twice the Price" is left as the floor of the source's 2–10× range. Genome tags untouched.